Back to Screener

Enhabit, Inc. (EHAB)

Price$13.73

Favorite Metrics

Price vs S&P 500 (26W)65.47%
Price vs S&P 500 (4W)-7.40%
Market Capitalization$702.56M

All Metrics

P/CF (Annual)9.94x
Book Value / Share (Quarterly)$10.53
P/TBV (Annual)0.94x
Revenue Growth (3Y)-0.35%
Cash Flow / Share (Quarterly)$1.30
Price vs S&P 500 (YTD)44.88%
Gross Margin (TTM)49.04%
Net Profit Margin (TTM)-0.43%
EPS (TTM)$-0.09
10-Day Avg Trading Volume0.98M
EPS Excl Extra (TTM)$-0.09
Revenue Growth (5Y)-0.34%
EPS (Annual)$-0.09
ROI (Annual)-0.47%
Gross Margin (Annual)49.04%
Net Profit Margin (5Y Avg)-3.32%
Cash / Share (Quarterly)$0.86
Revenue Growth QoQ (YoY)4.73%
ROA (Last FY)-0.39%
Revenue Growth TTM (YoY)2.44%
EBITD / Share (TTM)$1.13
ROE (5Y Avg)-8.07%
Operating Margin (TTM)1.52%
Cash Flow / Share (Annual)$1.30
P/B Ratio1.32x
P/B Ratio (Quarterly)0.87x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)1.04x
Net Interest Coverage (TTM)1.04x
ROA (TTM)-0.38%
EV / EBITDA (TTM)19.19x
EPS Incl Extra (Annual)$-0.09
Current Ratio (Annual)1.63x
Quick Ratio (Quarterly)1.50x
3-Month Avg Trading Volume1.14M
52-Week Price Return78.65%
EV / Free Cash Flow (Annual)16.83x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$9.77
P/S Ratio (Annual)0.66x
Asset Turnover (Annual)0.91x
52-Week High$14.22
Operating Margin (5Y Avg)-0.46%
EPS Excl Extra (Annual)$-0.09
CapEx CAGR (5Y)6.36%
26-Week Price Return72.36%
Quick Ratio (Annual)1.50x
13-Week Price Return25.99%
Total Debt / Equity (Annual)0.84x
Current Ratio (Quarterly)1.63x
Enterprise Value$1,107.255
Revenue / Share Growth (5Y)-0.70%
Asset Turnover (TTM)0.87x
Revenue / Employee (Annual)$0
Pretax Margin (Annual)0.13%
Cash / Share (Annual)$0.86
3-Month Return Std Dev47.94%
Gross Margin (5Y Avg)50.21%
Net Income / Employee (TTM)$-0
EBITDA CAGR (5Y)-16.56%
ROE (Last FY)-0.86%
Net Interest Coverage (Annual)1.04x
EPS Basic Excl Extra (Annual)$-0.09
P/FCF (TTM)10.68x
Receivables Turnover (TTM)7.23x
EV / Free Cash Flow (TTM)16.83x
Total Debt / Equity (Quarterly)0.84x
EPS Incl Extra (TTM)$-0.09
Receivables Turnover (Annual)7.23x
ROI (TTM)-0.45%
P/S Ratio (TTM)0.66x
Pretax Margin (5Y Avg)-2.56%
Revenue / Share (Annual)$20.87
Tangible BV / Share (Annual)$9.77
Forward P/E22.74x
Free OCF CAGR (5Y)25.31%
Price vs S&P 500 (52W)44.01%
Year-to-Date Return48.81%
5-Day Price Return-1.58%
EPS Normalized (Annual)$-0.09
ROA (5Y Avg)-2.95%
Net Profit Margin (Annual)-0.43%
Month-to-Date Return-2.63%
EBITD / Share (Annual)$1.14
Operating Margin (Annual)1.52%
LT Debt / Equity (Annual)0.79x
P/CF (TTM)9.94x
ROI (5Y Avg)-3.48%
LT Debt / Equity (Quarterly)0.79x
EPS Basic Excl Extra (TTM)$-0.09
P/TBV (Quarterly)0.94x
P/B Ratio (Annual)0.87x
Pretax Margin (TTM)0.13%
Book Value / Share (Annual)$10.53
Price vs S&P 500 (13W)23.61%
Beta1.01x
P/FCF (Annual)10.68x
Revenue / Share (TTM)$20.87
ROE (TTM)-0.84%
52-Week Low$6.47

Analyst Recommendations

Jan 2026
Feb 2026
Mar 2026
Apr 2026
3.82
4.08
3.67
2.55

Industry Peers — Home Health Care(7)

SymbolP/E Ratio (Annual)Revenue Growth TTM (YoY)Operating Margin (TTM)ROE (TTM)Price
EHABEnhabit, Inc.
2.44%1.52%-0.84%$13.73
BTSGBrightSpring Health Services, Inc. Common Stock
48.53x14.59%2.29%10.71%$47.81
BTSGUBrightSpring Health Services, Inc. Tangible Equity Unit
48.53x14.59%2.29%10.71%$158.10
CHEChemed Corporation
19.40x4.06%13.37%23.92%$385.77
OPCHOption Care Health, Inc. Common Stock
21.68x13.03%5.98%15.39%$28.88
ADUSAddus HomeCare Corp.
18.23x23.21%9.74%9.24%$93.52
AHCOAdaptHealth Corp. Common Stock
13.65x-0.49%2.80%-4.43%$12.67
AVAHAveanna Healthcare Holdings Inc. Common Stock
6.54x15.48%10.30%188.02%$6.84

About

Enhabit Inc operates a diversified home healthcare platform providing Medicare-certified home health and hospice services across the United States. The company's Home Health segment, its primary revenue driver, delivers a comprehensive suite of clinical services including skilled nursing, physical therapy, occupational therapy, speech therapy, and home health aide services to adult patients. Complementing this offering, its Hospice segment provides specialized care for patients with life-limiting illnesses, focusing on symptom management and quality of life rather than curative treatment.